 Aeterna Zentaris Inc. AEZS AEZS the Company, a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that the Company has received a positive decision from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC the Staff, granting the Companys request for an extension through October 5, 2020 to achieve compliance with the minimum 2.5 million stockholders equity requirement for continued listing on The Nasdaq Capital Market. The Staffs determination followed the Companys submission of its compliance plan for the Staffs consideration on May 26, 2020. The Company is pursuing a number of initiatives to increase stockholders equity, the completion of which are expected to enable it to achieve compliance with the minimum stockholders equity requirement by no later than October 5, 2020 and to thereafter maintain compliance with the listing requirements. 